Nippon India Pharma Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹2011 Cr | ₹8459 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.14 | 1.82 |
| Manager | Dhruv Muchhal | Sailesh Raj Bhan |
| ISIN Code | INF179KC1HL7 | INF204K01968 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -1.07% | -1.62% |
| 6 Month | 6.01% | 1.58% |
| 1 Year | 3.44% | -1.45% |
| 3 Year | - | 21.6% |
| 5 Year | - | 15.35% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | -1.12% | -1.66% |
| 1 Year | 7.48% | 2.66% |
| 3 Year | - | 15.82% |
| 5 Year | - | 16.04% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 27.59% | 16.62% |
| 3 Year | - | 20.93% |
| 5 Year | - | 20.36% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | - | 15.23% |
| Sharp | - | 0.92% |
| Beta | - | 0.91% |
| Alpha | - | -0.55% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Dhruv Muchhal | Sailesh Raj Bhan |
| Total AUM | ₹520687 Cr | ₹96086 Cr |
| Funds Managed | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 10.4 | 1.34 |
| Mid Cap | 30.37 | 35.32 |
| Small Cap | 32.94 | 30.74 |
| Large Cap | 26.28 | 32.6 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.62 | 0.55 |
| Basic Materials | 2.97 | - |
| Healthcare | 95.41 | 99.45 |
Top Comparisons
ICICI Prudential Commodities Fund - Growth Option
3Y Returns15.59%
INVESCO INDIA ESG INTEGRATION STRATEGY FUND REGULAR GROWTH
3Y Returns13.25%
Franklin India ELSS Tax Saver Fund-Growth
3Y Returns17.04%
Sundaram Value Fund - Regular Plan - Growth
3Y Returns12.76%
ITI Mid Cap Fund Regular - Growth
3Y Returns22.97%
Sundaram Mid Cap Fund Regular Plan - Growth
3Y Returns23.39%
HSBC Large & Mid Cap Fund - Regular Growth
3Y Returns19.8%
Edelweiss Large & Mid Cap Fund - Regular Plan - Growth Option
3Y Returns17.84%